Yunnan Baiyao Group Co., Ltd.
Yunnan Baiyao was developed in 1902. It is a well-known trademark in China, the initial National Innovative Enterprise and a world renowned time-honored Chinese brand.
The sales revenue of Yunnan Baiyao increased nearly 105 times from 23.2 million yuan to 24.315 billion yuan since 1999. The compounded annual growth rate reached 29.49% and accumulated profits and taxes are around 33 billion yuan. Its key economic indexes has led the Chinese pharmaceutical industry since 2006, and its market value exceeded 100 billion yuan in 2017. It has the highest ROI among listed companies in stock markets of Shanghai and Shenzhen in the past two decades.
With innovation of technologies, products and management, Yunnan Baiyao renovates muti-brands system and extends successfully from pharmaceutical brands into the fields of health and services. It continuously tops the pharmaceutical industry in China Brands Lists issued by Interbrand, Hu Run and BRANDZ? .
Recently, the businesses of Yunnan Baiyao involve pharmaceuticals, personal healthcare, Chinese medical resources, medicine logistics and so on. Its products are sold well in China, Southeast Asia and gradually enter the market of European countries, USA, Japan etc. Hundreds of millions of people have used the products.
Yunnan Baiyao completed mixed ownership reform in 2016, which brought vitality and vigor to this century-aged company. It will implement endogenous growth with extensive development, spare no efforts to build healthcare industry, provide better products and services for customers and represent China to participate in global competition.
